Amgen (NASDAQ:AMGN) announced today that Repatha® (evolocumab), when added to statins or other low-density lipoprotein cholesterol (LDL-C)-lowering treatments, reduced the risk of first major adverse ...

Evolocumab (Repatha) reduced risk of a first major cardiovascular (CV) event in patients with diabetes but no known atherosclerosis in a substudy of the VESALIUS-CV trial. The PCSK9 inhibitor cut ...

New-onset vitreous floaters, with or without flashes, confer an increased risk for retinal detachment (RD), according to a study published in the March issue of the Annals of Family Medicine.

Women who consistently met physical activity guidelines throughout middle age had half the risk of dying from any cause ...

Unruly Republic: President Trump is urging the Senate GOP to abolish the filibuster as a way to pass the 'SAVE America Act.' ...

Headlines say “no amount of alcohol is safe,” but a closer look at the science — and how risk statistics are reported — tells ...

Previous research has suggested a potential link between type 2 diabetes and dementia risk. However, a new study suggests ...

My husband left me at 60 to have a baby with a younger woman. Here's what it taught me.

The 2026 Chartered Risk Management Institute of Nigeria (CRMI) Risk Outlook, has highlighted macroeconomic instability, ...

A new systematic review and meta-analysis suggests that nerandomilast (Jascayd; Boehringer Ingelheim), an oral therapy for ...

Global scientists and public health experts are urging governments to adopt risk-proportionate regulation for nicotine ...

Central banks are adopting a firmer tone once more, and financial / crypto markets are responding with notable intensity : CoinShares.